Senior Medical Oncologist and the Director of Clinical Research Laboratory of Translational Immuno-Oncology
Dr. Cohen is a medical oncologist specializing in skin cancer and cancer. His research focuses among other areas on the uniqueness of the brain as a site for mestastases at the Hadassah Cancer Research Institute. Jonathan and the research students in his lab, are researching peptide-drug immune-modulators, cellular therapy for solid tumors including engineered T cells and mechanisms of immune-checkpoint inhibitor toxicity. HCRI is currently cooperating through Dr. Cohen with the Israel Precision Medicine Partnership – IPMP to research the contribution of metastatic site to the specific tumor microenvironment and develop predictive biomarkers for cancer immunotherapy.
Dr. Cohen is also the Director of Clinical Research at the Sharett Institute of Oncology Hadassah Hebrew University Medical Center, where he is engaged in expanding access to novel drugs at all stages of development; offering potentially life-saving treatments to cancer patients while providing an excellent and professional service to established pharma companies as well as local and international emerging biotech companies. In addition, he is a member of the gastro-intestinal medical oncology team at Hadassah Medical Center, accumulating extensive experience employing cancer-immunotherapy including cellular therapies and handling their toxicities. Jonathan holds a PhD in neuroscience and has been awarded the Exemplary Physician Award from the Hebrew University of Jerusalem. Dr. Cohen heads the national committee of the Israeli oncology society (ISCORT) for prioritizing novel drugs for inclusion in the national coverage scheme.
Liquid biopsy reveals collateral tissue damage in cancer. the Journal Citation Indicator Insight, 2022. Asael Lubotzky, Hai Zemmour, Daniel Neiman, Marc Gotkine, Netanel Loyfer, Sheina Piyanzin, Bracha-Lea Ochana, Roni Lehmann-Werman, Daniel Cohen, Joshua Moss, Judith Magenheim, Maureen F. Loftus, Lauren Brais, Kimmie Ng, Raul Mostoslavsky, Brian M. Wolpin, Aviad Zick, Myriam Maoz, Albert Grinshpun, Anatoli Kustanovich, Chen Makranz, Jonathan E. Cohen, Tamar Peretz, Ayala Hubert, Mark Temper, Azzam Salah, Shani Avniel-Polak, Simona Grozinsky-Glasberg, Kirsty L. Spalding, Ariel Rokach, Tommy Kaplan, Benjamin Glaser, Ruth Shemer and Yuval Dor.
Subtyping of Small Cell Lung Cancer using plasma cell-free nucleosomes. bioRxiv, 2022. Gavriel Fialkoff, Nobuyoki Takahashi, Israa Sharkia, Jenia Gutin, Lorinc Pongor, Arun Rajan, Samantha Nichols, Linda Sciuto, Rasa Vilimas, Chante Graham, Parth Desai, Miriam Maoz, Yakir Rottenberg, Nevo Shoshan, Hovav Nechushtan, Tamar Peretz, Diana Roame, Paula Carter, Rajesh Kumar, Ayala Hubert, Jonathan E Cohen, Deep Upadhyay, Azzam Salah, Mark Temper, Albert Grinshpun, William Douglas Figg Sr, Aviad Zick, Ronen Sadeh, Nir Friedman, Anish Thomas.
